Areas of Focus
- Pharmacokinetics and Pharmacodynamics of Traditional Chinese Medicine
- Research on the Pharmacokinetics of New Chinese Medicines
Work Experience
- 2014-09~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
- 2010-07~2014-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
- 2005-09~2010-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Ph.D. Student
- 2001-09~2005-06 - Zhejiang University - Bachelor's Student
Academic Background & Achievements
- 2005-09--2010-06 Ph.D.: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- 2001-09--2005-06 Bachelor's: Zhejiang University
Publications
- Research on the Compatibility and Detoxification of Toxic Traditional Chinese Medicine Evodia Rutaecarpa, Not mentioned, 2024
- Composition analysis of compound Shenhua tablet, a seven-herb Chinese medicine for IgA nephropathy: evaluation of analyte-capacity of the assays, Not mentioned, 2024
- In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes, 4th Author, 2024
- Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2, 12th Author, 2023
- Pharmacokinetic research of new Chinese medicines, 2nd Author, 2023
- Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management, 7th Author, 2022
- Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines, 3rd Author, 2022
- Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots., Not mentioned, 2020
- Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions, Not mentioned, 2019
- Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions, Not mentioned, 2019
